Goldman Sachs’s Merck MRK Stock Holding History

Goldman Sachs’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.42B	Buy	20,133,379 +784,661	+4%	+$90.6M	0.28%	50
2025 Q4	$2.04B	Buy	19,348,718 +4,327,351	+29%	+$406M	0.25%	55
2025 Q3	$1.26B	Sell	15,021,367 -3,370,286	-18%	-$278M	0.15%	112
2025 Q2	$1.46B	Buy	18,391,653 +4,024,221	+28%	+$320M	0.2%	81
2025 Q1	$1.29B	Sell	14,367,432 -2,731,720	-16%	-$255M	0.21%	78
2024 Q4	$1.7B	Buy	17,099,152 +2,272,626	+15%	+$234M	0.27%	60
2024 Q3	$1.68B	Buy	14,826,526 +2,293,551	+18%	+$272M	0.27%	62
2024 Q2	$1.55B	Buy	12,532,975 +876,795	+8%	+$113M	0.26%	61
2024 Q1	$1.54B	Sell	11,656,180 -450,043	-4%	-$55.5M	0.27%	60
2023 Q4	$1.32B	Sell	12,106,223 -914,714	-7%	-$94.9M	0.24%	67
2023 Q3	$1.34B	Buy	13,020,937 +457,054	+4%	+$49.3M	0.29%	56
2023 Q2	$1.45B	Sell	12,563,883 -1,071,957	-8%	-$122M	0.31%	48
2023 Q1	$1.45B	Buy	13,635,840 +1,389,705	+11%	+$150M	0.33%	47
2022 Q4	$1.36B	Buy	12,246,135 +142,535	+1%	+$14.6M	0.33%	38
2022 Q3	$1.04B	Sell	12,103,600 -960,511	-7%	-$85.7M	0.26%	56
2022 Q2	$1.19B	Buy	13,064,111 +2,444,607	+23%	+$217M	0.3%	46
2022 Q1	$871M	Buy	10,619,504 +2,860,675	+37%	+$226M	0.18%	83
2021 Q4	$595M	Sell	7,758,829 -2,779,545	-26%	-$221M	0.12%	153
2021 Q3	$792M	Buy	10,538,374 +2,879,685	+38%	+$219M	0.17%	101
2021 Q2	$596M	Sell	7,658,689 -1,088,737	-12%	-$81M	0.13%	133
2021 Q1	$643M	Sell	8,747,426 -235,504	-3%	-$17.4M	0.16%	101
2020 Q4	$701M	Buy	8,982,930 +892,551	+11%	+$68.3M	0.18%	92
2020 Q3	$640M	Sell	8,090,379 -3,014,909	-27%	-$236M	0.18%	92
2020 Q2	$819M	Sell	11,105,288 -3,645,188	-25%	-$274M	0.25%	64
2020 Q1	$1.08B	Sell	14,750,476 -1,382,260	-9%	-$109M	0.38%	36
2019 Q4	$1.4B	Buy	16,132,736 +1,559,841	+11%	+$128M	0.36%	40
2019 Q3	$1.17B	Sell	14,572,895 -1,109,040	-7%	-$88.9M	0.34%	42
2019 Q2	$1.25B	Sell	15,681,935 -4,310,493	-22%	-$330M	0.36%	34
2019 Q1	$1.59B	Sell	19,992,428 -5,965,372	-23%	-$446M	0.48%	22
2018 Q4	$1.89B	Buy	25,957,800 +10,809,737	+71%	+$763M	0.6%	17
2018 Q3	$1.03B	Sell	15,148,063 -2,235,852	-13%	-$142M	0.26%	54
2018 Q2	$1.01B	Sell	17,383,915 -6,944,325	-29%	-$392M	0.27%	49
2018 Q1	$1.26B	Buy	24,328,240 +5,467,285	+29%	+$295M	0.32%	33
2017 Q4	$1.01B	Sell	18,860,955 -1,256,332	-6%	-$69.6M	0.24%	57
2017 Q3	$1.23B	Buy	20,117,287 +3,629,084	+22%	+$220M	0.3%	34
2017 Q2	$1.01B	Buy	16,488,203 +515,686	+3%	+$31.4M	0.26%	49
2017 Q1	$968M	Buy	15,972,517 +3,072,697	+24%	+$186M	0.26%	50
2016 Q4	$725M	Buy	12,899,820 +497,699	+4%	+$29.1M	0.2%	69
2016 Q3	$739M	Buy	12,402,121 +573,603	+5%	+$33.5M	0.22%	62
2016 Q2	$650M	Buy	11,828,518 +2,100,589	+22%	+$112M	0.21%	61
2016 Q1	$491M	Sell	9,727,929 -2,075,209	-18%	-$102M	0.16%	102
2015 Q4	$595M	Buy	11,803,138 +1,906,386	+19%	+$96.1M	0.19%	89
2015 Q3	$466M	Sell	9,896,752 -3,997,588	-29%	-$212M	0.16%	111
2015 Q2	$755M	Sell	13,894,340 -1,200,585	-8%	-$67.3M	0.23%	59
2015 Q1	$828M	Buy	15,094,925 +2,925,106	+24%	+$166M	0.27%	49
2014 Q4	$659M	Buy	12,169,819 +1,360,414	+13%	+$75.8M	0.21%	73
2014 Q3	$611M	Sell	10,809,405 -8,281,993	-43%	-$465M	0.19%	81
2014 Q2	$1.05B	Sell	19,091,398 -2,458,592	-11%	-$134M	0.33%	39
2014 Q1	$1.17B	Sell	21,549,990 -2,728,409	-11%	-$141M	0.38%	31
2013 Q4	$1.16B	Sell	24,278,399 -1,365,304	-5%	-$62.4M	0.38%	30
2013 Q3	$1.16B	Buy	25,643,703 +4,163,881	+19%	+$190M	0.43%	24
2013 Q2	$952M	Buy	+21,479,822	New	+$959M	0.37%	33

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs's MRK Position: Q1 2026 in Review

Goldman Sachs increased its Merck (MRK) stake by 4.1% in Q1 2026, buying an estimated $90.6M and bringing the position to 20,133,379 shares worth $2.42B. The position accounts for 0.28% of the portfolio, ranked #50.

Goldman Sachs first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Goldman Sachs held 20,133,379 shares of Merck worth $2.42B as of Q1 2026.
Goldman Sachs bought 784,661 Merck shares in Q1 2026, an estimated $90.6M.
Merck made up 0.28% of Goldman Sachs's portfolio in Q1 2026, its #50 holding.
Goldman Sachs first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.